Tcw Group Inc Abb Vie Inc. Transaction History

Tcw Group Inc

$11 Billion
Q2 2024

A detailed history of Tcw Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Tcw Group Inc holds 401,439 shares of ABBV stock, worth $77.7 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

401,439

Previous 333,352 20.42%

Holding current value

$77.7 Million

Previous $60.7 Million 13.43%

% of portfolio

0.63%

Previous 0.62%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $10.5 Million - $12.3 Million	68,087 Added 20.42%	401,439 $68.9 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $1.17 Million - $1.33 Million	-7,319 Reduced 2.15%	333,352 $60.7 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $4.37 Million - $4.92 Million	31,748 Added 10.28%	340,671 $52.8 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $9.8 Million - $11.3 Million	-73,381 Reduced 19.19%	308,923 $46 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $3.05 Million - $3.79 Million	22,996 Added 6.4%	382,304 $51.5 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $4.96 Million - $5.71 Million	-34,297 Reduced 8.71%	359,308 $57.3 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $4.98 Million - $5.97 Million	36,010 Added 10.07%	393,605 $63.6 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $2.26 Million - $2.59 Million	-16,805 Reduced 4.49%	357,595 $48 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $3.09 Million - $3.93 Million	-22,479 Reduced 5.66%	374,400 $57.3 Million
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $985,890 - $1.22 Million	7,470 Added 1.92%	396,879 $64.3 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $7.15 Million - $9.04 Million	66,538 Added 20.61%	389,409 $52.7 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $811,832 - $921,551	-7,630 Reduced 2.31%	322,871 $34.8 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $1.69 Million - $1.89 Million	16,105 Added 5.12%	330,501 $37.2 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $2.86 Million - $3.15 Million	27,955 Added 9.76%	314,396 $34 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $2.17 Million - $2.93 Million	27,002 Added 10.41%	286,441 $30.7 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $482,814 - $566,664	5,620 Added 2.21%	259,439 $22.7 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $7.82 Million - $10.5 Million	106,537 Added 72.34%	253,819 $24.9 Million
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $9.5 Million - $14.4 Million	147,282 New	147,282 $11.2 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $1.04 Million - $1.28 Million	-13,300 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $485,982 - $540,259	-5,466 Reduced 29.13%	13,300 $1.26 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $202,633 - $239,761	-2,257 Reduced 10.74%	18,766 $1.74 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $1.01 Million - $1.35 Million	-10,981 Reduced 34.31%	21,023 $1.99 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $148,132 - $162,439	1,654 Added 5.45%	32,004 $3.1 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $1.03 Million - $1.31 Million	14,699 Added 93.92%	30,350 $2.7 Million
Q2 2017 Aug 11, 2017	BUY	N/A	15,651	15,651 $1.14 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account